MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SLS
  4. News
SLS
Quote
Short
News
Articles
Message Board

SELLAS Life Sciences Group Inc. (NASDAQ : SLS ) News

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) News Releases

SLS News Releases
SLS : NASDAQ
GlobeNewswire
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
SLS : NASDAQ
GlobeNewswire
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
SLS : NASDAQ
SeekingAlpha
Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst
SLS : NASDAQ
SeekingAlpha
Why I'm Selling Sellas Life Sciences Ahead Of The REGAL Reveal
SLS : NASDAQ
GlobeNewswire
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
SLS : NASDAQ
GlobeNewswire
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
SLS : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Tue, Jan 06, 2026 as of 4:00 pm ET
SLS : NASDAQ
SeekingAlpha
Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
SLS : NASDAQ
Investing News Network
Top 5 Small-cap Biotech Stocks of 2025
SLS : NASDAQ
GlobeNewswire
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
Back to Start Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.